Nothing written yet for this company.
Medy-Tox, Inc. (086900) raised its damages claim against Daewoong Pharma (069620) to ₩500 billion, Dailian reported Friday.
| Period | 086900 | KOSDAQ | Difference |
|---|---|---|---|
| 1 week | -2.1% | -3.0% | +0.9% |
| 1 month | -9.5% | +4.2% | -13.7% |
| 3 months | -18.8% | -22.5% | +3.7% |
| 6 months | -38.4% | -16.9% | -21.5% |
| Year to date | -42.4% | -12.1% | -30.3% |
| 1 year | -41.9% | +1.0% | -42.9% |
Closed at 4% of the way from its 52-week low (₩66,900) to its 52-week high (₩138,600).
Medy-Tox, Inc. makes pharmaceutical ingredients in South Korea. It is listed on KOSDAQ, was founded in 2000, is based in North Chungcheong, and has revenue of hundreds of billions of won.
| Sector | Biopharma | Employees | |
| Market | KOSDAQ | Founded | 2000 |
| Korean name | 메디톡스 | Head office | North Chungcheong |
| Symbol | Last Price |
|---|---|
| 085660Chabiotech Co., Ltd. | ₩8,090 +2.1% |
| 476060Onconic Therapeutics, Inc. | ₩16,440 -3.9% |
| 041960Komipharm International Co., Ltd. | ₩9,710 +3.5% |
| 317450Myungin Pharm | ₩44,650 +0.0% |
| 001060JW Pharmaceutical | ₩27,500 +1.3% |
| 456160G2GBIO, Inc. | ₩37,950 +5.7% |
| 019170Shinpoong Pharmaceutical Co., Ltd. | ₩10,010 -0.9% |
| 358570GI Innovation, Inc. | ₩8,090 +6.2% |
| 397030April Bio Co., Ltd. | ₩17,800 +6.1% |
| 249420Ildong Pharm | ₩15,030 -0.5% |